Wall Street expects a year-over-year increase in earnings on higher revenues when Cencora (COR) reports results for the quarter ended December 2024. While this widely-known consensus outlook is ...

Wells Fargo analyst Stephen Baxter raised the firm’s price target on Cencora (COR) to $251 from $237 and keeps an Equal Weight rating on the shares following new guidance. The firm notes Cencora ...

Wells Fargo analyst Stephen Baxter maintained a Hold rating on Cencora (COR – Research Report) yesterday and set a price target of $251.00. The company’s shares closed yesterday at $255.10.

Cencora, Inc. (NYSE:COR – Get Free Report)’s share price reached a new 52-week high on Monday after JPMorgan Chase & Co. raised their price target on the stock from $289.00 to $301.00.

This is an increase from Cencora’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend was Friday, November 15th. This represents a $2.20 dividend on an annualized basis ...

Harrow's "Harrow Cares" program, in partnership with Cencora, aims to improve access and affordability of eye care treatments for retina specialists and patients. The program includes a patient ...

Shares of Cencora (COR) have been strong performers lately, with the stock up 13.4% over the past month. The stock hit a new 52-week high of $256.81 in the previous session. Cencora has gained 13. ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and ...